Trial Profile
Short Term Atorvastatin Regime for Vasculopathic Surgical (STAR-VaS) Patients Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Myocardial ischaemia
- Focus Pharmacodynamics
- Acronyms STAR-VaS
- 11 Jun 2018 Status changed from active, no longer recruiting to completed.
- 24 Oct 2011 Planned end date changed from 1 Aug 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 20 Mar 2010 Planned end date changed from Dec 2010 to Aug 2010 as reported by ClinicalTrials.gov.